Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 19;11(4):868.
doi: 10.3390/vaccines11040868.

Examining the Impact of Key Factors on COVID-19 Vaccination Coverage in India: A PLS-SEM Approach

Affiliations

Examining the Impact of Key Factors on COVID-19 Vaccination Coverage in India: A PLS-SEM Approach

Veena Dhawan et al. Vaccines (Basel). .

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, numerous factors determined the performance of COVID-19 vaccination coverage. The purpose of this study is to examine the influence of factors such as government stewardship, planning and implementation, and community participation on COVID-19 vaccination coverage. This study applied partial least square structured equation modeling (PLS-SEM) by analyzing 187 responses from the stakeholders involved in vaccination programs in four select states of India. This study empirically validates a framework for improving vaccination coverage by confirming the significant impact of planning and implementation on vaccination coverage followed by government stewardship and community participation. Additionally, this study highlights the individual impact of each factor on vaccination coverage. Based on the findings, strategic recommendations were proposed that can be utilized for formulating policy-level actions to facilitate the vaccination program.

Keywords: COVID-19; India; community participation; government stewardship; partial least square; vaccination coverage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Model for empirical testing.
Figure 2
Figure 2
Empirical validation of the model.

Similar articles

Cited by

References

    1. Dubé E., MacDonald N.E. COVID-19 vaccine hesitancy. Nat. Rev. Nephrol. 2022;18:409–410. doi: 10.1038/s41581-022-00571-2. - DOI - PMC - PubMed
    1. Ung C.O.L., Hu Y., Hu H., Bian Y. Investigating the intention to receive the COVID-19 vaccination in Macao: Implications for vaccination strategies. BMC Infect. Dis. 2022;22:1–17. doi: 10.1186/s12879-022-07191-y. - DOI - PMC - PubMed
    1. WHO Weekly Epidemiological Update on COVID-19—8 February 2022. 2022. [(accessed on 8 February 2022)]. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on....
    1. Bagcchi S. The world’s largest COVID-19 vaccination campaign. Lancet Infect. Dis. 2021;21:323. doi: 10.1016/S1473-3099(21)00081-5. - DOI - PMC - PubMed
    1. Flacco M.E., Acuti Martellucci C., Baccolini V., De Vito C., Renzi E., Villari P., Manzoli L. COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis. Front. Med. 2022;9:3313. doi: 10.3389/fmed.2022.1023507. - DOI - PMC - PubMed

LinkOut - more resources